Clinical Data Combined With Modeling and Simulation Indicate Unchanged Drug‐Drug Interaction Magnitudes in the Elderly-Reference-Cited by-同舟云学术

Clinical Data Combined With Modeling and Simulation Indicate Unchanged Drug‐Drug Interaction Magnitudes in the Elderly

Published:2020-09-18 Issue:2 Volume:109 Page:471-484
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Stader Felix¹²³,Courlet Perrine⁴,Kinvig Hannah⁵,Penny Melissa A.²³,Decosterd Laurent A.⁴,Battegay Manuel¹³,Siccardi Marco⁵,Marzolini Catia¹³⁵

Affiliation:

1. Division of Infectious Diseases and Hospital Epidemiology Departments of Medicine and Clinical Research University Hospital Basel Basel Switzerland

2. Swiss Tropical and Public Health Institute Basel Switzerland

3. University of Basel Basel Switzerland

4. Service of Clinical Pharmacology Lausanne University Hospital and University of Lausanne Lausanne Switzerland

5. Department of Molecular and Clinical Pharmacology Institute of Translational Medicine University of Liverpool Liverpool UK

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

OPO-Stiftung

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2017

Reference48 articles.

1. Ortman J.M. Velkoff V.A.&Hogan H.An aging nation: the older population in the United States (2014). Accessed July 10 2020.

2. European Union ‐ Eurostats.People in the EU ‐ population projections (2017). Accessed February 6 2019.

4. Non‐AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care;Palella J.F.;AIDS,2019

5. Eurostat.Medicine use statistics (2014). Accessed November 15 2018.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically based pharmacokinetic (PBPK) modelling of oral drug absorption in older adults – an AGePOP review;European Journal of Pharmaceutical Sciences;2023-09

2. Managing Drug–Drug Interactions in Older Adults;The Journal of Clinical Pharmacology;2023-07-26

3. Mechanistic Modeling of the Drug‐Drug Interaction Between Efavirenz and Dolutegravir: Is This Interaction Clinically Relevant When Switching From Efavirenz to Dolutegravir During Pregnancy?;The Journal of Clinical Pharmacology;2023-06

4. Physiologically Based Pharmacokinetic Model for Older Adults and Its Application in Geriatric Drug Research;Current Drug Metabolism;2023-03

5. Physiologically-based pharmacokinetic modeling to predict drug-drug interactions of dabigatran etexilate and rivaroxaban in the Chinese older adults;European Journal of Pharmaceutical Sciences;2023-03